Healthcare - Medical - Devices - NASDAQ - US
$ 1.85
8.19 %
$ 3.37 M
Market Cap
-0.07
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
3056.43%
EBIT
Estimate
88.32%
Net Income
Estimate
18.58%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Talis Biomedical Corporation
TLIS has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TLIS
EBIT FORECAST
EBIT Forecast Chart TLIS
NET INCOME FORECAST
Net Income Chart TLIS